Advertisement

Inhibitory effect of effective fraction of Salvia officinalis on aldose reductase activity: strategy to reduce complications of type 2 diabetes

  • Somayeh Amraee
  • Seifollah Bahramikia
Research Article
  • 13 Downloads

Abstract

Aldose reductase (AR) is the key enzyme of the polyol pathway, which plays an important role in the pathogenesis of diabetic complications. AR inhibitors can be used as an important strategy in the treatment of diabetic complications. The aim of the present study was to investigate effect of different fractions of Salvia officinalis on the bovine lens aldose reductase activity. For this purpose, the phenolic and flavonoid contents, IC50 values of different fractions of the S. officinalis to neutralize the DPPH free radicals were first measured. Then, attempts were made to investigate the effect of these fractions on the AR enzyme activity. Results indicated that ethyl acetate fraction had the highest of phenolic and flavonoid contents by 412.6 ± 1.55 and 372.5 ± 6.47 mg/ml, respectively. Also, the ethyl acetate fraction showed the lowest IC50 content of 1.18 μg/ml for scavenging of the free radicals and 9.25 μg/ml for the inhibition of AR activity. According to the Lineweaver–Burk plot, the ethyl acetate fraction acts as an uncompetitive enzyme inhibitor. These findings revealed that all fractions showed inhibitory effect on AR activity, where in ethyl acetate fraction it was found to be maximum which may be due to its high phenolic and flavonoid content.

Keywords

Aldose reductase Diabetic complications Salvia officinalis Ethyl acetate fraction 

Notes

Acknowledgements

The authors appreciate the joint financial support of this investigation by the research Council of Lorestan University.

Compliance with ethical standards

Ethical statement

N/A.

Conflict of interest

This manuscript described has not been published before; not under consideration for publication anywhere else; and has been approved by all co-authors.

References

  1. Arabi S, Arshami S, Haghparast AR (2014) Effect of Salvia officinalis L. extract on biochemical blood parameters in male rats. J Zanjan Univ Med Sci 22(94):34–43Google Scholar
  2. Blois MS (1958) Antioxidant determination by the use of a stable free radical. Nature 181:1199–1200CrossRefGoogle Scholar
  3. Bors W, Michel C, Stettmaier K (1997) Antioxidant effects of flavonoids. BioFactors 6(4):399–402CrossRefPubMedGoogle Scholar
  4. Bower A, Marquez S, de Mejia EG (2016) The health benefits of selected culinary herbs and spices found in the traditional Mediterranean diet. Crit Rev Food Sci Nutr 56(16):2728–2746CrossRefPubMedGoogle Scholar
  5. Garcia CS, Menti C, Lambert APF, Barcellos T, Moura S, Calloni C, Henriques JA (2016) Pharmacological perspectives from Brazilian Salvia officinalis (Lamiaceae): antioxidant, and antitumor in mammalian cells. Anais da Academia Brasileira de Ciências 88(1):281–292CrossRefPubMedGoogle Scholar
  6. Glisic S, Ivanovic J, Ristic M, Skala D (2010) Extraction of sage (Salvia officinalis L.) by supercritical CO2: kinetic data, chemical composition and selectivity of diterpenes. J Supercrit Fluids 52(1):62–70CrossRefGoogle Scholar
  7. Hayman S, Kinoshita JH (1965) Isolation and properties of lens aldose reductase. J Biol Chem 240(2):877–882PubMedGoogle Scholar
  8. Howes MJR, Perry E (2011) The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging 28(6):439–468CrossRefPubMedGoogle Scholar
  9. Imanshahidi M, Hosseinzadeh H (2006) The pharmacological effects of Salvia species on the central nervous system. Phytother Res 20(6):427–437CrossRefPubMedGoogle Scholar
  10. Kim TH, Kim JK, Kang YH, Lee JY, Kang IJ, Lim SS (2013) Aldose reductase inhibitory activity of compounds from Zea mays L. BioMed Res Int 2013:1–8Google Scholar
  11. Lean ME, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A (1999) Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48(1):176–181CrossRefPubMedGoogle Scholar
  12. Lee EH, Song DG, Lee JY, Pan CH, Um BH, Jung SH (2008a) Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol Pharm Bull 31(8):1626–1630CrossRefPubMedGoogle Scholar
  13. Lee YS, Kang YH, Jung JY, Kang IJ, Han SN, Chung S, Lim SS (2008b) Inhibitory constituents of aldose reductase in the fruiting body of Phellinus linteus. Biol Pharm Bull 31(4):765–768CrossRefPubMedGoogle Scholar
  14. Lee YS, Kim SH, Jung SH, Kim JK, Pan CH, Lim SS (2010) Aldose reductase inhibitory compounds from Glycyrrhiza uralensis. Biol Pharm Bull 33(5):917–921CrossRefPubMedGoogle Scholar
  15. Livingstone C, Lyall H, Gould GW (1995) Hypothalamic GLUT 4 expression: a glucose-and insulin-sensing mechanism? Mol Cell Endocrinol 107(1):67–70CrossRefPubMedGoogle Scholar
  16. Moon HI, Jung JC, Lee J (2006) Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis. Bioorg Med Chem 14(22):7592–7594CrossRefPubMedGoogle Scholar
  17. Obrosova IG (2002) How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol 50:3–35CrossRefPubMedGoogle Scholar
  18. Obrosova IG (2005) Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 7(11–12):1543–1552CrossRefPubMedGoogle Scholar
  19. Obrosova IG, Fathallah L (2000) Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study. Diabetologia 43(8):1048–1055CrossRefPubMedGoogle Scholar
  20. Obrosova IG, Van Huysen C, Fathallah L, Cao X, Greene DA, Stevens MJ (2002) An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J 16(1):123–125CrossRefPubMedGoogle Scholar
  21. Obrosova IG, Chung SS, Kador PF (2010) Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev 26(3):172–180CrossRefPubMedGoogle Scholar
  22. Perry EK, Pickering AT, Wang WW, Houghton P, Perry NS (1998) Medicinal plants and Alzheimer’s disease: Integrating ethnobotanical and contemporary scientific evidence. J Altern Complement Med 4(4):419–428CrossRefPubMedGoogle Scholar
  23. Rakover Y, Ben-Arye E, Goldstein LH (2008) The treatment of respiratory ailments with essential oils of some aromatic medicinal plants. Harefuah 147(10):783–788PubMedGoogle Scholar
  24. Slinkard K, Singleton VL (1977) Crude phenol analysis: automation and comparison with manual methods. Am J Enol Vitic 28(1):49–55Google Scholar
  25. Suzen S, Buyukbingol E (2003) Recent studies of aldose reductase enzyme inhibition for diabetic complications. Cur Med Chem 10(15):1329–1352CrossRefGoogle Scholar
  26. Tang WH, Martin KA, Hwa J (2012) Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol 3(87):1–8Google Scholar
  27. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84CrossRefPubMedGoogle Scholar
  28. Varma SD, Mikuni I, Kinoshita JH (1975) Flavonoids as inhibitors of lens aldose reductase. Science 188(4194):1215–1216CrossRefPubMedGoogle Scholar
  29. Yoon HN, Lee MY, Kim JK, Suh HW, Lim SS (2013) Aldose reductase inhibitory compounds from Xanthium strumarium. Arch Pharm Res 36(9):1090–1095CrossRefPubMedGoogle Scholar
  30. Zhishen J, Mengcheng T, Jianming W (1999) The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 64(4):555–559CrossRefGoogle Scholar

Copyright information

© Institute of Korean Medicine, Kyung Hee University 2018

Authors and Affiliations

  1. 1.Department of Biology, Faculty of ScienceLorestan UniversityKhorramabadIran

Personalised recommendations